I WANT TO eat. I need to eat. I shouldn’t eat. I just ate. Why do I want to eat more? Oh my god: Why am I constantly thinking about this? This is so ridiculous. I hate this. I’m ashamed of this. This ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

The Xreal 1S serves as a refreshed model in the One Series lineup, replacing the original Xreal One glasses from 2024. It features a Full HD 1200p display with a 16:10 aspect ratio and delivers peak ...

The latest spatial display glasses from Xreal can convert all in-display content to 3D, and with the Neo DisplayPort and battery hub, it can stream games from the Nintendo Switch 2. Here's what Xreal ...

If you’re looking for a simple, sweet treat to gift friends or family this holiday season, homemade peanut brittle is an easy win. The recipe is so straightforward you may not even need a trip to the ...

Novo Nordisk is seeking FDA approval for an experimental obesity shot, CagriSema (cagrilintide and semaglutide), according to a Dec. 18 news release from the Denmark-based drugmaker. CagriSema is a ...

Please provide your email address to receive an email when new articles are posted on . New research suggests GLP-1 receptor agonists may help manage inflammatory diseases. This is part one of a ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

Weight-loss drugs are coming for a new kind of customer. “You don’t need to be obese to start a GLP-1,” reads an ad from a telehealth startup, the words scrawled in icing on a cake. Another one ...

Treatment with a GLP-1 receptor agonist (RA) may offer a survival advantage in patients with colon cancer and obesity. In a real-world analysis of nearly 7000 patients with colon cancer, those taking ...

It's no secret that triple-A game development is becoming unsustainably expensive, so to support major titles, big studios should look to diversify the scale of their productions. That's according to ...